NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Capricor Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
Nature4y
Exosomes—the next frontier in biomarker discovery and diagnostics
ExosomeDx harnesses biological information from exosomes for biomarker discovery and diagnostic development. The company’s pipeline of products includes the ExoDx Prostate test, the first ...
Nature3y
Isolating exosomes
A new exosome isolation kit, developed by FUJIFILM Wako Pure Chemical, could help researchers establish a better understanding of the extracellular vesicles’ many functions. Exosomes are small ...